Skip to content
Malawi Clinical GuidelinesGuidelinesGet app

3.2.3

Severe Malaria in Pregnancy

Guidelines for the Treatment of Malaria in Malawi, 6th Edition, 2025. Chapter 3, Malaria in Pregnancy.

Treatment

In the management of severe malaria in pregnancy, special attention must be paid to anaemia, hypoglycaemia, and pulmonary oedema.

Box 4 — Management of complications in pregnancy (see the 8-8-8 schedule above)
Box 4 — Management of complications in pregnancy (see the 8-8-8 schedule above). Open the image to zoom.

Treatment

Parenteral Artesunate is the recommended treatment for severe malaria in all pregnant women. Give artesunate 2.4 mg/kg body weight IV bolus or IM on admission (at 0 hour), repeat at 12 hours and 24 hours, then once daily, for no more than 6 days. However, once patient can take oral treatment and at least 24 hours of parenteral therapy has been administered, discontinue parenteral therapy and commence a full 3-day course of either DP or LA.

Pregnant women in all trimesters can be treated with parenteral Quinine if Parenteral Artesunate is not available or contraindicated. The dose is 20 mg/kg body weight as loading dose, followed by a maintenance dose of 10 mg/kg 12-hourly until patient is able to take oral medication and at least 24 hours of parenteral therapy has been administered.

Switch to DP or LA as soon as the patient is able to take oral medication and at least 24 hours of parenteral therapy has been administered.

Check doses against the printed guideline and your clinical judgement before treating a patient. Spotted an error? Report it from the contact links below.

Need this without data?

The app holds every guideline on your device, with calculators, bookmarks and notes.